| PERIOD ENDING | 31-Dec-03 | 31-Dec-02 | | Total Revenue |
-
|
-
| | Cost of Revenue |
-
|
-
| | | Gross Profit |
-
|
-
| | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 3,102 | 2,262 | | Non Recurring |
-
|
-
| | Others | 5,171 | 3,675 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (8,273) | (5,937) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 20,682 | 14,983 | | Earnings Before Interest And Taxes | 12,409 | 9,046 | | Interest Expense | 689 | 283 | | Income Before Tax | 11,720 | 8,764 | | Income Tax Expense | 4,136 | 3,392 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 7,583 | 5,371 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 7,583 | 5,371 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $7,583 | $5,371 |
|
1.52% Nasdaq 
Income Statement
